M2 Pharma - Research and Development

Stem Cell and Research Therapy Publishes Preclinical Data Highlighting the Potential of a NurOwn Derived Exosome-Based Treatment for COVID-19 ARDS

20 January 2021 - - US-based adult stem cell therapies developer BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) is highlighting the peer-reviewed publication of a preclinical study in the ...

Qiagen Plans 1Q21 Resubmit of EUA Submission in the US for QIAreach SARS-CoV-2 Antigen Test

20 January 2021 - - German sample and assay technologies provider Qiagen N.V. (NYSE: QGEN) plans to resubmit in 1Q21 its QIAreach SARS-CoV-2 Antigen Test to the US Food and Drug Administration for Eme...

US FDA Accepts for Priority Review Application for Opdivo Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma

20 January 2021 - - The US Food and Drug Administration has accepted its supplemental Biologics License Application for Opdivo (nivolumab), in combination with fluoropyrimidine- and platinum...

Aveo Oncology Receives Commitment for an Incremental USD 10m Loan in Addition to Current Tranched, USD 35m Debt Facility with Hercules Capital

20 January 2021 - - US-based Aveo Oncology (NASDAQ: AVEO) has received a commitment letter for an incremental USD 10m loan from Hercules Capital, Inc. (NYSE: HTGC) and its affiliates, to be added to t...

Russia's RDIF files for registration of its Sputnik V COVID-19 vaccine with EMA in Europe

20 January 2021 - The official twitter account, promoting the Sputnik V COVID-19 vaccine, tweeted on 20 January 2021 that Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, ha...

Lightpoint Medical awarded CE Mark for world's first approved robotic gamma probe for targeted cancer surgery

20 January 2021 - Lightpoint Medical reported on Tuesday the receipt of the CE Mark approval for the launch of the world's first robotic gamma probe SENSEI across hospitals in Europe for intra-op...